Mosaic's Selloff Sparks Contrarian Debate Amid Sulfur and Demand Pressures

What happened

Mosaic's stock has sold off sharply due to rising sulfur costs and weak phosphate demand in Q4 2025, as confirmed in recent SEC filings. A Seeking Alpha article frames this as a classic contrarian buy opportunity, citing potential offsets from fixed-cost absorption and Chinese export restrictions. However, the DeepValue master report maintains a 'WAIT' rating, highlighting that FY2025 data shows phosphate volumes fell to 5.9 million tonnes and sulfur costs surged 80%, squeezing margins and prompting production idling. The report stresses that the investment case hinges on observable proof points over the next few quarters, including phosphate sales volumes rebounding to at least 1.9 million tonnes and working-capital release improving free cash flow. While management targets over 7 million tonnes of phosphate production and lower conversion costs in FY2026, these remain aspirational without clear demand recovery or sulfur cost relief.

Implication

The Seeking Alpha bullish call overlooks the structural sulfur deficit and recent weak demand highlighted in SEC filings, which contradict a near-term rebound. Mosaic's valuation is attractive at 5.1x EV/EBITDA, but the phosphate segment remains volatile and could drag earnings if sulfur-driven idling persists or inventory release fails. Potash provides stability, but phosphate's swing factor requires close monitoring of quarterly sales volumes against the 1.7-1.9 million tonne guide and sulfur cost trends. A prudent approach is to wait for confirmation of working-capital unwind and margin improvement, as the DeepValue report advises, to avoid premature exposure to downside risks. Investors should trim above $32 and consider entry near $23 only if phosphate shipments beat expectations and inventories decline sequentially.

Thesis delta

The Seeking Alpha article introduces a bullish contrarian perspective but does not alter the core investment thesis from the DeepValue report. The thesis remains unchanged: Mosaic is a wait-and-see opportunity until phosphate demand and sulfur costs show sustainable improvement, with no new data in the article justifying a shift from the 'WAIT' rating.